KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Pension (2016 - 2025)

Historic Pension for Eli Lilly (LLY) over the last 17 years, with Q2 2025 value amounting to $1.3 billion.

  • Eli Lilly's Pension fell 534.36% to $1.3 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $1.3 billion, marking a year-over-year decrease of 534.36%. This contributed to the annual value of $1.3 billion for FY2024, which is 961.22% down from last year.
  • As of Q2 2025, Eli Lilly's Pension stood at $1.3 billion, which was down 534.36% from $1.3 billion recorded in Q1 2025.
  • Eli Lilly's 5-year Pension high stood at $4.0 billion for Q1 2021, and its period low was $1.3 billion during Q4 2024.
  • Moreover, its 5-year median value for Pension was $1.4 billion (2023), whereas its average is $1.9 billion.
  • In the last 5 years, Eli Lilly's Pension soared by 1529.75% in 2021 and then plummeted by 5275.6% in 2022.
  • Eli Lilly's Pension (Quarter) stood at $2.0 billion in 2021, then tumbled by 33.21% to $1.3 billion in 2022, then rose by 10.24% to $1.4 billion in 2023, then dropped by 9.61% to $1.3 billion in 2024, then increased by 3.38% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q2 2025, $1.3 billion for Q1 2025, and $1.3 billion during Q4 2024.